Mutations on TNFRSF13B have been identified in about 8%–10% of CVID patients but are sometimes found also in healthy subjects who were not hypogammaglobulinemic [34, 35, 36], hence they are generally considered disease‐associated rather than pathogenic [37, 38, 39]. This evidence concerns the gene TNFRSF13B and common variable immunodeficiency.